Direct Plan · Growth · Index Funds · Scheme code 147622
NAV₹38.2304as on 30 Oct 2026
Fund houseMotilal Oswal Mutual Fund
CategoryIndex Funds
Plan & optionDirect · Growth
History7.0 years
Returns (%)
1M
3M
6M
1Y
3Y
5Y
7Y
10Y
Launch
This scheme
1.72
4.38
7.84
13.13
17.93
18.11
—
—
22.88
Nifty 100 benchmark
0.25
3.49
-1.52
1.84
10.52
9.38
—
—
12.79
Index Funds category median
—
—
—
0.39
7.46
6.40
—
10.97
—
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
17.9%
0.64
0.98
1.14
6.25%
-37.2%
83.40
Nifty 100 benchmark
14.4%
0.28
0.40
—
—
-37.0%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
36 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
1,472
-5.9%
20.2%
114.4%
6%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
How it behaves against its benchmark
Up capture
Down capture
Correlation
Tracking error
Information ratio
Treynor
130%
105%
0.91
7.6%
0.90
9.58
Up capture is how much of the benchmark's gain this scheme kept in the months the
benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it
on the up side is the combination every fund is trying for and few reach.
Measured over the 36 months this scheme and
Nifty 100 share.
Motilal Oswal Nifty Midcap 150 Index Fund
Direct Plan · Growth
Allocation
By asset
Equity
99.12%
REITs / InvITs
0.94%
By market cap
Large Cap
5.71%
Mid Cap
91.81%
Small Cap
2.54%
Concentration
Number of stocks
150
Top 5 stocks
9.37%
Top 10 stocks
16.85%
Top 20 stocks
29.60%
Lines in the filing
152
Largest holding
2.08%
Largest sector
Pharmaceuticals & Biotechnology 9.17%
Effective stocks
109.5
Sectors held
41
Cash
-0.06%
Effective stocks is what the concentration works out to: a fund holding
150 names but most of its money in a few
behaves like a fund of 110. Cash includes repo and TREPS, which
every fund parks money in overnight.
Sector split
Pharmaceuticals & Biotechnology
9.17%
Banks
8.68%
Finance
6.83%
Electrical Equipment
5.94%
Retailing
5.62%
Capital Markets
4.72%
Auto Components
4.59%
IT - Software
4.43%
Consumer Durables
4.33%
Insurance
3.84%
Realty
3.39%
Industrial Products
2.99%
Leisure Services
2.81%
Financial Technology (Fintech)
2.71%
Power
2.45%
Healthcare Services
2.06%
Beverages
2.04%
Telecom - Services
1.92%
Fertilizers & Agrochemicals
1.85%
Chemicals & Petrochemicals
1.68%
Motilal Oswal Nifty Midcap 150 Index Fund
Direct Plan · Growth · holdings
Top 30 holdings
#
Company
Sector
Shares held
Value ₹ cr
% of fund
1
Multi Commodity Exchange of India Limited
Capital Markets
251,163
83
2.08%
2
The Federal Bank Limited
Banks
2,431,875
77
1.93%
3
Laurus Labs Limited
Pharmaceuticals & Biotechnology
383,497
76
1.90%
4
One 97 Communications Limited
Financial Technology (Fintech)
423,940
71
1.78%
5
Hero MotoCorp Limited
Automobiles
127,831
67
1.68%
6
The Indian Hotels Company Limited
Leisure Services
864,621
63
1.58%
7
Coforge Limited
IT - Software
342,903
60
1.50%
8
Bharat Heavy Electricals Limited
Electrical Equipment
1,434,631
60
1.49%
9
IndusInd Bank Limited
Banks
648,516
58
1.46%
10
AU Small Finance Bank Limited
Banks
572,504
58
1.45%
11
Persistent Systems Ltd
IT - Software
107,109
57
1.42%
12
Dixon Technologies (India) Limited
Consumer Durables
41,010
54
1.34%
13
IDFC First Bank Limited
Banks
6,538,553
53
1.33%
14
Bharat Forge Limited
Auto Components
273,611
53
1.32%
15
GE Vernova T&D India Limited
Electrical Equipment
122,003
51
1.28%
16
Lenskart Solutions Limited
Retailing
722,005
49
1.24%
17
Life Insurance Corporation Of India
Insurance
1,249,008
49
1.24%
18
Lupin Limited
Pharmaceuticals & Biotechnology
239,182
49
1.22%
19
Indus Towers Limited
Telecom - Services
1,267,493
47
1.18%
20
Suzlon Energy Limited
Electrical Equipment
11,978,911
47
1.18%
21
Info Edge India Ltd
Retailing
381,563
47
1.16%
22
Aurobindo Pharma Limited
Pharmaceuticals & Biotechnology
272,127
46
1.14%
23
Ashok Leyland Limited
Agricultural, Commercial & Construction Vehicles
2,818,205
43
1.09%
24
FSN E-Commerce Ventures Limited
Retailing
1,347,799
43
1.08%
25
Marico Limited
Agricultural Food & other Products
521,873
41
1.03%
26
Fortis Healthcare Limited
Healthcare Services
513,062
40
0.99%
27
United Spirits Limited
Beverages
290,890
39
0.99%
28
APL Apollo Tubes Limited
Industrial Products
179,226
39
0.98%
29
ICICI Lombard General Insurance Company Limited
Insurance
239,780
38
0.95%
30
Embassy Office Parks REIT
Unclassified
862,975
37
0.94%
Motilal Oswal Nifty Midcap 150 Index Fund
Direct Plan · Growth · where the money sits
What the manager did last month
Between the filings of 30 Jun 2026 and 31 Jul 2026.
A position grows because the manager bought or because the price rose; only the share count separates them.
Bought
Sold
New positions
Sold out of
Price move of holdings
₹120 cr
₹0 cr
0
0
+2.52%
Stock
Shares traded
Shares
Price
Value ₹ cr
Added to
Coforge Limited
75,263
+30.1%
+17.4%
13.0
JSW Infrastructure Ltd
259,502
+87.4%
-3.0%
8.1
BSE Limited
9,953
+2.7%
-5.7%
3.6
The Federal Bank Limited
59,492
+2.6%
+8.7%
2.1
Laurus Labs Limited
9,357
+2.6%
+19.7%
1.7
Hero MotoCorp Limited
3,151
+2.7%
+12.3%
1.7
Multi Commodity Exchange of India Limited
6,136
+2.6%
-5.1%
1.7
IndusInd Bank Limited
15,840
+2.6%
+9.6%
1.6
Not equity
Previous filing
This filing
Change
Cash, repo and TREPS
₹0 cr
₹0 cr
+₹0 cr
The list above is stocks and fund units. Treasury bills, repo and money-market
lines roll over every month by design — they are not decisions, so they are totalled here rather
than listed as activity.
A ₹10,000 monthly SIP over five years
Invested
Value
Gain
XIRR
₹600,000
₹934,120
₹334,120
17.76%
XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has
been invested for a different length of time.
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 31 Oct 2026.